AR mutations that alter drug binding can reduce efficacy, while the phenomenon of anti-androgen withdrawal—where stopping treatment temporarily regresses disease—highlights the complexity of AR signaling in PCa [13,14,15]. Here, AR is linked to posterior cortical atrophy.